Modern possibilities for the correction of menopausal symptoms in patients with breast cancer, depending on the molecular biological characteristics of the tumor (literature review)
| Autor: | I. V. Vysotskaya, E. A. Kim, M. V. Geletko, F. E. Misrikhanova, V. Yu. Kirsanov |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2023 |
| Předmět: |
menopausal symptoms
breast cancer vasomotor symptoms adjuvant hormonal therapy correction of menopausal symptoms chemotherapy endocrine therapy serotonin reuptake inhibitors gabapentin fesolinetant klimadynon triple negative breast cancer brca mutations her2-positive breast cancer cimicifuga Gynecology and obstetrics RG1-991 |
| Zdroj: | Опухоли женской репродуктивной системы, Vol 19, Iss 3, Pp 43-53 (2023) |
| Druh dokumentu: | article |
| ISSN: | 1994-4098 1999-8627 |
| DOI: | 10.17650/1994-4098-2023-19-3-43-53 |
| Popis: | Breast cancer (BC) ranks first in cancer incidence among women. For successful treatment of BC, depending on the molecular type and stage of the disease, chemotherapy is used, the side effects of which are manifested by menopausal symptoms, sexual dysfunction, and depressive states. However, not all patients after BC receive appropriate therapy for menopausal symptoms, what significantly worsens their quality of life. One of the symptoms that brings the most severe discomfort is the vasomotor symptom, a form of temperature dysfunction with peripheral vasodilation and increased cutaneous blood flow that results in increased heat loss. There are several types of drugs that are used to prevent menopausal symptoms in patients taking endocrine chemotherapy, many of which are in the experimental phase of development. In this review, we will try to identify proven effective and safe methods for correcting menopausal symptoms in women who underwent chemotherapy and endocrine therapy for BC. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|